CPT Enzyme: Critical for Energy Production in Mitochondria (P42410)

Target Name: Carnitine O-Palmitoyltransferase (CPT)

NCBI ID: P42410

Carnitine O-Palmitoyltransferase (CPT)

Other Name(s): Carnitine O-Palmitoyltransferase | Carnitine palmitoyltransferase

CPT Enzyme: Critical for Energy Production in Mitochondria

Carnitine O-Palmitoyltransferase (CPT) is an enzyme involved in the transport of long-chain fatty acids into mitochondria, where they can be oxidized to produce energy. CPT is a critical enzyme in the transport of fatty acids into mitochondria, and is essential for the function of the mitochondria. Mutations in the CPT gene have been linked to a variety of diseases, including cardiovascular disease, obesity, and neurological disorders.

The CPT gene is located on chromosome 16, and its encoded protein is a member of the superfamily of transmembrane proteins known as Ca2+-ATP-dependent chloride channels. These channels are involved in the regulation of intracellular signaling pathways, including the production of reactive oxygen species (ROS) that can damage cellular components and contribute to a variety of diseases.

CPT is a critical enzyme in the transport of long-chain fatty acids into mitochondria, where they can be oxidized to produce energy.

Mutations in the CPT gene have been linked to a variety of diseases, including cardiovascular disease, obesity, and neurological disorders.

The CPT gene is located on chromosome 16, and its encoded protein is a member of the superfamily of transmembrane proteins known as Ca2+-ATP-dependent chloride channels.

CPT is a protein that is expressed in many different tissues throughout the body, including muscle, heart, brain, and liver. It is involved in the transport of long-chain fatty acids into mitochondria, where they can be oxidized to produce energy. This process is critical for the function of the mitochondria, as they are the primary producers of energy in the body.

CPT is regulated by a variety of factors, including levels of ATP, Ca2+, and cholesterol. It is also influenced by the levels of other nutrients and substances in the body, including fatty acids, which can affect its structure and function.

The CPT gene is located on chromosome 16, and its encoded protein is a member of the superfamily of transmembrane proteins known as Ca2+-ATP-dependent chloride channels.

CPT is a critical enzyme in the transport of long-chain fatty acids into mitochondria, where they can be oxidized to produce energy.

Mutations in the CPT gene have been linked to a variety of diseases, including cardiovascular disease, obesity, and neurological disorders. For example, studies have shown that individuals with certain genetic mutations, such as those found in the CPT gene, are at increased risk of developing heart disease and other conditions associated with the production of reactive oxygen species (ROS).

In addition, CPT is also a potential drug target for a variety of diseases. For example, inhibition of CPT has been shown to be effective in treating obesity and other conditions associated with the production of ROS. Additionally, CPT has also been shown to be involved in the regulation of cellular signaling pathways, including the production of ROS. This suggests that it may be a useful target for the treatment of a variety of diseases.

Overall, CPT is a critical enzyme involved in the transport of long-chain fatty acids into mitochondria, where they can be oxidized to produce energy. Its regulation by various factors, including ATP, Ca2+, and cholesterol, makes it an attractive target for the development of new drugs for a variety of diseases. Additionally, its role in the regulation of cellular signaling pathways makes it a potential target for the treatment of a variety of conditions.

Protein Name: Carnitine O-Palmitoyltransferase (CPT) (nonspecified Subtype)

The "Carnitine O-Palmitoyltransferase (CPT) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Carnitine O-Palmitoyltransferase (CPT) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets